Healthcare provider profile · identity verified

Nishith Shah, M.D.

Family Practice · ROCKFORD, IL · NPI 1902255656

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	128
Levothyroxine Sodium	Levothyroxine Sodium	327	71
Lisinopril	Lisinopril	273	74
Losartan Potassium	Losartan Potassium	260	76
Amlodipine Besylate	Amlodipine Besylate	229	70
Metoprolol Succinate	Metoprolol Succinate	220	53
Tamsulosin Hcl	Tamsulosin Hcl	172	44
Omeprazole	Omeprazole	165	44
Tramadol Hcl	Tramadol Hcl	163	44
Gabapentin	Gabapentin	157	38
Metformin Hcl	Metformin Hcl	155	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	154	51
Simvastatin	Simvastatin	152	34
Alprazolam	Alprazolam	149	44
Albuterol Sulfate Hfa	Albuterol Sulfate	131	55
Rosuvastatin Calcium	Rosuvastatin Calcium	121	36
Famotidine	Famotidine	118	33
Furosemide	Furosemide	110	39
Montelukast Sodium	Montelukast Sodium	108	31
Pantoprazole Sodium	Pantoprazole Sodium	105	33
Fluticasone Propionate	Fluticasone Propionate	90	37
Sertraline Hcl	Sertraline Hcl	88	23
Hydrochlorothiazide	Hydrochlorothiazide	87	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	28
Metoprolol Tartrate	Metoprolol Tartrate	81	24
Eliquis	Apixaban	77	21
Alendronate Sodium	Alendronate Sodium	76	19
Clopidogrel	Clopidogrel Bisulfate	76	23
Baclofen	Baclofen	75	27
Glipizide	Glipizide	72	17
Spironolactone	Spironolactone	72	15
Zolpidem Tartrate	Zolpidem Tartrate	66	15
Buspirone Hcl	Buspirone Hcl	64	22
Clonazepam	Clonazepam	60	17
Duloxetine Hcl	Duloxetine Hcl	59	15
Meloxicam	Meloxicam	59	suppressed
Azelastine Hcl	Azelastine Hcl	57	37
Allopurinol	Allopurinol	54	13
Atenolol	Atenolol	54	17
Metformin Hcl Er	Metformin Hcl	52	18
Escitalopram Oxalate	Escitalopram Oxalate	51	17
Hydroxyzine Hcl	Hydroxyzine Hcl	50	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	suppressed
Finasteride	Finasteride	48	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	11
Nifedipine Er	Nifedipine	46	11
Citalopram Hbr	Citalopram Hydrobromide	44	15
Pravastatin Sodium	Pravastatin Sodium	44	11
Prednisone	Prednisone	44	29
Farxiga	Dapagliflozin Propanediol	43	14
Mirtazapine	Mirtazapine	43	suppressed
Ozempic	Semaglutide	43	suppressed
Trazodone Hcl	Trazodone Hcl	42	13
Potassium Chloride	Potassium Chloride	40	13
Triamcinolone Acetonide	Triamcinolone Acetonide	40	20
Glipizide Er	Glipizide	39	17
Jardiance	Empagliflozin	39	14
Ezetimibe	Ezetimibe	38	14
Tizanidine Hcl	Tizanidine Hcl	38	18
Carvedilol	Carvedilol	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	17
Lovastatin	Lovastatin	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	11
Xarelto	Rivaroxaban	34	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	25
Pregabalin	Pregabalin	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Celecoxib	Celecoxib	29	17
Topiramate	Topiramate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Ketoconazole	Ketoconazole	28	12
Oxybutynin Chloride Er	Oxybutynin Chloride	28	11
Donepezil Hcl	Donepezil Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Fosinopril Sodium	Fosinopril Sodium	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Glycopyrrolate	Glycopyrrolate	24	suppressed
Primidone	Primidone	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Mounjaro	Tirzepatide	23	suppressed
Nabumetone	Nabumetone	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Cephalexin	Cephalexin	22	19
Chlorthalidone	Chlorthalidone	22	suppressed
Minocycline Hcl	Minocycline Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	16
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Sulfasalazine	Sulfasalazine	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Vascepa	Icosapent Ethyl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nexium	Esomeprazole Magnesium	19	suppressed
Phenytoin	Phenytoin	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Nystatin	Nystatin	18	14
Valacyclovir	Valacyclovir Hcl	18	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Azithromycin	Azithromycin	14	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Ibuprofen	Ibuprofen	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Steglatro	Ertugliflozin Pidolate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Glimepiride	Glimepiride	13	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Droxidopa	Droxidopa	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error